Log In Sign up
The largest database of trusted experimental protocols
> Physiology > Mental Process > Shame

Shame

Shame is an emotional experience characterized by intense feelings of self-consciousness, inadequacy, and a sense of being negatively evaluated by others.
It is a complex social emotion that can have profound impacts on an individual's mental health and behavior.
Shame is often associated with experiences of social rejection, public humiliation, or the failure to meet societal expectations.
This MeSH term provides a comprehensive overview of the psychological, physiological, and behavioral manifestations of shame, as well as its role in various mental health conditions and interpersonal dynamics.
Reserachers can leverage this description to enhance their understanding of shame and its implications for scientific inquiry and clinical practice.

Most cited protocols related to «Shame»

1
Coding Stigma Mechanisms in HIV Measures
For each scale, survey items were coded in order to determine which stigma mechanisms were measured by the instrument. This coding scheme was driven by the definitions of the six stigma processes provided previously in this review. Therefore, survey instruments examining the perspective of HIV uninfected people were coded for items measuring prejudice, stereotypes, and/or discrimination. Items were coded as prejudice if they measured negative affect toward HIV infected people. Popular prejudice items included anger (e.g., “Angry” [43 (link)]), disgust (“Disgusted with sinfulness” [38 (link)]), and shaming (e.g., “People with HIV should be ashamed of themselves” [50 (link)]). Items were coded as stereotypes if they measured potentially inaccurate thoughts and beliefs about HIV infected people. Many of these items measured beliefs about the types of people who get HIV/AIDS (“Only disgusting people get AIDS” [35 (link)]) and the types of behavior in which they engage (“Most women with HIV/AIDS are prostitutes or sex workers” [42 (link)]). Items were coded as discrimination if they measured behavioral expressions of prejudice directed at HIV infected people or support of discriminatory social policy. These items often involved social distancing (e.g., “If I was in public or private transport, I would not like to sit next to someone with HIV” [50 (link)]) or the removal of rights (e.g., “Persons with AIDS should not be eligible for welfare benefits from the state or federal governments” [39 (link)]).
Survey instruments examining the perspective of HIV infected people were coded for items measuring enacted stigma, anticipated stigma, and internalized stigma. Items were coded as enacted stigma if they measured perceived experiences of prejudice and/or discrimination. These items spanned a wide range of experiences, including discriminatory actions (e.g., “At the hospital/clinic, I was left in a soiled bed” [11 (link)]), verbal abuse (e.g., “Someone told me HIV is what I deserve for how I lived” [9 (link)]), and social rejection (e.g., “I feel some friends have rejected me because of my illness” [8 (link)]). Items were coded as anticipated stigma if they measured the expectation of experiencing future prejudice and discrimination. Some of these items referenced discriminatory behaviors (e.g., “Most employers would not employ me because I am HIV+” [50 (link)]) while others measured the anticipation of dislike by others (e.g. “My neighbors would not like living next door if they knew I had HIV” [50 (link)]). Finally, measures were coded as assessing internalized stigma if they measured the application of shame and/or negative beliefs associated with HIV/AIDS to the self. Items assessing shame (e.g., “I feel ashamed that I have HIV” [50 (link)]), guilt, (e.g., “I feel guilty because I have HIV” [9 (link)]), and worthlessness (e.g., “I felt completely worthless” [11 (link)]) were common examples.
Earnshaw V.A, & Chaudoir S.R. (2009). From Conceptualizing to Measuring HIV Stigma: A Review of HIV Stigma Mechanism Measures. AIDS and behavior, 13(6), 1160-1177.
Publication 2009
Acquired Immunodeficiency Syndrome Anger Drug Abuse Feelings Friend Guilt Sex Workers Shame Stereotypic Movement Disorder Thinking Woman
2
Assessing Homosexual Stigma Experiences
Two general dimensions of homosexual stigma were assessed: experienced and internalized stigma. The items in these variables were worded for male homosexuality only, not for transgender identity because of the technical difficulties and costs involved in changing the wording in CASI based on the respondent’s identity. Yet they were general enough to be applicable to GBT, and the number of transgender participants was relatively small (N = 94, 15%).
Experienced stigmatization was measured by 20 items reflecting events across the life span and across a variety of contexts (e.g., work environment, family) and actions (e.g., verbal and physical abuse, displacement). The response choices ranged from 1 = never to 4 = many times. Maximum likelihood exploratory factor analysis was conducted on this measure to determine the underlying factor structure, and the factors were rotated using the “promax” method to allow the factors to correlate. Appendix A presents all stigma factors, items, Cronbach’s alpha coefficients, and scale means and standard deviations. Four factors emerged: (1) childhood experiences of maltreatment, (2) adult harassment and abuse, (3) social rejection and maltreatment, and (4) family experiences. Intercor-relations among factors ranged from .50 to .60. Items from each factor were averaged to create four sub-scales.
Internalized stigmatization was assessed in a similar fashion. A total of 17 items comprise this measure. Results of factor analysis showed four factors: feelings of shame, blame, wanting to change one’s sexuality, and endorsement of normative masculinity (see Appendix A; factor inter-correlations range from .30 to .65).
Ramirez-Valles J., Kuhns L.M., Campbell R.T, & Diaz R.M. (2010). Social Integration and Health: Community Involvement, Stigmatized Identities, and Sexual Risk in Latino Sexual Minorities. Journal of health and social behavior, 51(1), 30-47.
Publication 2010
Abuse, Physical Adult Drug Abuse Feelings Homosexuals Masculinity Shame Transgendered Persons
3
Assessing Moral Injury in Healthcare Professionals
The original 10-item MISS-M-SF assesses 10 theoretically grounded dimensions of MI based on the writings and research of MI experts (Litz et al. 2009 (link); Shay 1994 ; Shay 2014 (link); Drescher et al. 2011 (link); Brock and Lettini 2012 ; Nash et al. 2013 (link); Currier et al. 2015 (link)). The 10 dimensions of MI assessed by this measure are betrayal, guilt, shame, moral concerns, loss of trust, loss of meaning, difficulty forgiving, self-condemnation, religious struggle and loss of religious faith. To our knowledge, this is the only measure of MI that assesses both psychological and religious symptoms (Koenig et al. 2019a (link)). The MISS-M-SF has strong internal reliability, test–retest reliability, and criterion, discriminant, and convergent validity in military personnel suffering from PTSD symptoms (Koenig et al. 2018b (link)). For the current study, we adapted the language of each item on the MISS-M-SF so that it would apply to health professionals caring for patients in medical settings, calling it the Moral Injury Symptom Scale-Health Professional version (MISS-HP) (Koenig et al. 2020 ). Each of the 10 items of the MISS-HP has response options on a visual analogue scale ranging from 1 (“strongly disagree”) to 10 (“strongly disagree). Four of the items are worded positively and six negatively in order to reduce response bias (Furnham 1986 (link)). After recoding the positively worded items (5, 6, 7, 10), item scores are summed to create a total score ranging from 10 to 100, with higher scores indicating greater MI.
In order to determine convergent validity for the MISS-HP, the 17-item Expressions of Moral Injury Scale (EMIS-M) was utilized (Currier et al. 2018 (link)). This scale was originally developed to assess symptoms of MI in former or current military personnel. For the purposes of this study, the wording of items on the EMIS-M was modified by Currier so that the statements would apply specifically to healthcare professionals (EMIS-HP). Each of the 17 items is rated on a Likert scale from 1 (strongly disagree) to 5 (strongly agree) with all items worded in the same direction. Higher total scores indicate the number and severity of MI symptoms, reflecting maladaptive behaviors and internal experiences associated with the moral challenges involved in delivering clinical care. The EMIS-HP includes only the psychological symptoms of MI. The internal reliability α of the EMIS-HP in the current sample was 0.93.
Mantri S., Lawson J.M., Wang Z, & Koenig H.G. (2020). Identifying Moral Injury in Healthcare Professionals: The Moral Injury Symptom Scale-HP. Journal of Religion and Health, 59(5), 2323-2340.
Publication 2020
6-pyruvoyl-tetrahydropterin synthase deficiency Guilt Health Care Professionals Military Personnel Moral Injury Nonalcoholic Steatohepatitis Shame Visual Analog Pain Scale
4
Workplace Stigma Reduction: Mental Health Protocol
The search strategy was reviewed independently by subject experts/librarians at the University of Calgary (for full database search strategies, please check the appendix). The following terms were used to search all trial registers and databases: stigma-related terms AND mental health-related terms AND workplace-related terms AND program evaluation-related terms. Limitations were applied with regards to restrictions in type of study design and type of participants as described above, as well as to studies on stigma related to physical health conditions or interventions aiming to reduce drug use (e.g. smoking cessation) unless they provided a quantitative measure on stigma related to drug use and didn’t target healthcare providers.
Stigma-related terms: stigma*, labeling, prejudice, social acceptance or social approval, social discrimination, social perception, stereotyped attitudes, shame, discrimination or disability discrimination, judgment, fairness, health services accessibility, treatment barriers.
Mental health-related terms: mental disorders, psychiatric patients, psychiatric symptoms, recovery disorders, relapse disorders, work-related illnesses, mental health, well-being.
Workplace-related terms: occupations, employment history, occupational adjustment, occupational tenure, personnel, professional personnel, working women, employment status, employability, reemployment, supported employment, occupational health, industrial and organizational psychology, working conditions, unemployment, personnel termination, downsizing, workplace*, quality of work life, occupational stress, organizational climate.
Program evaluation-related terms: mental illness (attitudes toward), mental health program evaluation or mental health programs, community mental health training or mental health inservice training or inservice training or professional development, program development, program evaluation, health promotion, health education or health knowledge or health literacy or social marketing or client education, structured clinical interview or interviews or psychodiagnostic interview or interviewers or interviewing or qualitative research or questioning or narratives or life review or narrative therapy or storytelling or health attitudes or attitudes or disabled (attitudes toward) or employee attitudes or employer attitudes or health personnel attitudes, or occupational attitudes or public opinion or work (attitude toward) or attitude measurement or attitude measures, campaign or initiative or aware or program or train or intervene or workshop or seminar or curriculum or booster session or strategy or implement or course or symposium or coach or mentor or blitz or policy or policies or guideline or recommendation or standard, questionnaires or mail surveys or surveys or telephone surveys.
Hanisch S.E., Twomey C.D., Szeto A.C., Birner U.W., Nowak D, & Sabariego C. (2016). The effectiveness of interventions targeting the stigma of mental illness at the workplace: a systematic review. BMC Psychiatry, 16, 1.
Full text: Click here
Publication 2016
Attitude of Health Personnel Climate Conferences Discrimination, Psychology Education of Patients Health Education Health Literacy Health Personnel Health Promotion Interviewers Mental Disorders Mental Health Mentors Narrative Therapy Patients Pharmaceutical Preparations Physical Examination Program Development Relapse Secondary Immunization Shame Social Perception Women, Working Workers
5
Assessment of Internalized Homophobia
In both the Crew 450 and eDAPT samples, participants were asked a series of 22 items to assess experiences of IH. This investigator-adapted scale first used five items from the Homosexual Attitudes Inventory (Nungesser, 1983 ), which were adapted to be more interpretable for a youth population. This is a measure frequently used to assess IH (Grey et al., 2013 (link)) and this scale has been highly correlated with other measures of IH, including one that shows post-intervention decreases in IH (Lin & Istael, 2012 ). This scale included items such as, “Sometimes I wish I were not gay” and “Sometimes I feel ashamed of my sexual orientation.” Next, the investigative team added 17 items to the scale in order to capture a broader conceptualization of IH, including items that tapped into experiences of shame, self-blame, normative masculinity and desire to change sexual orientation (Ramirez-Valles, Kuhns, Campbell, & Diaz, 2010 (link)). Participants indicated how much they agreed with each statement on a 4-point Likert scale from Strongly Disagree to Strongly Agree. It was administered at each time point in the Crew 450 sample and at baseline in the eDAPT sample. Responses were averaged, so that higher scores indicated greater IH. Additional information on scale construction and reliability is subsequently presented.
Puckett J.A., Newcomb M.E., Ryan D.T., Swann G., Garofalo R, & Mustanski B. (2016). Internalized Homophobia and Perceived Stigma: A Validation Study of Stigma Measures in a Sample of Young Men who Have Sex with Men. Sexuality research & social policy : journal of NSRC : SR & SP, 14(1), 1-16.
Publication 2016
Concept Formation Crow Feelings Homosexuals Masculinity Sexual Orientation Shame Youth

Most recents protocols related to «Shame»

1
Shame and Guilt in Obsessive-Compulsive Disorder
A total of 62 participants (38 women and 24 men) were examined in this study. Of these, 31 patients fulfilled the criteria of OCD [ICD-10 F42.X: mean age 35.2 (SD = 10.7) years] and 31 subjects formed the healthy control group [mean age 39.1 (SD = 15.0) years]. A detailed description of the groups can be found in Table 1.

Sociodemographic and clinical characteristics

TraitOCDN = 31HCN = 31p-value*
Age, mean (SD), years38,7 (11,9)39,6 (13,1)n. s
Gender
 Female n,19 (61,3%)19 (61,3%)n. s
 Male n,12 (38,7%)12 (38,7%)
Marital status
 Single, n17 (54,8%)12(38,7%)
 Married, n9 (29,0%)19 (61,3%)p = 0.009
 Divorced, n5 (16,1%)0
Current Partnership
 - No13 (41,9%)7 (22,6%)n. s
 - Yes18 (58,1%)24 (77,4%)
Graduation
 High school, n25 (80,7%)24 (77,4)
 Junior high school, n3 (9,7%)5 (16,1%)n. s
 Low school., n3 (9,7%)2 (6,5%)
Occupational status

 Current employment

(Including be a student), n

22 (71,0%)27 (87,1%)n. s
  No current Job,9 (29,0%)4 (12,9%)
Diagnosis (ICD-10)
 F42.0, n5 (16,1%)/
 F42.2, n26 (83,9%)
Age of onset
 mean (SD), years23,2 (9,1)/
Duration of illness
 mean (SD), years15,8 (10,8)/

*x2-Test/ t-Test; n. s. non-significant, OCD Obsessive–compulsive disorder, HC Healthy controls

All OCD patients were recruited and examined during their treatment at the Department of Psychiatry (LWL-University Hospital of the Medical Faculty of Ruhr-University Bochum, special outpatient clinic for OCDs). Examination of the healthy volunteers also took place at the LWL-University Hospital Bochum and recruitment was via notices and flyers.
Patients and healthy volunteers aged 18–67 years were included. Further inclusion criteria were a verbal IQ > 70, sufficient German language skills and the ability to give informed consent according to the Helsinki and ICH-GCP declarations. Exclusion criteria for the study were: severe somatic diseases; other mental diseases, such as reduced intelligence (ICD10 F70–F70.9), schizophrenia (ICD10 F20–F20.9) or organic brain disorders (ICD10 F06–F06.9, dependence on illegal drugs); acute suicidal tendencies or behaviour endangering others; and lack of informed consent to participate in the study.
Furthermore, psychopharmacotherapy was not an exclusion criterion for patients with OCD. In this respect, 96.8% of the patients (n = 30) received monotherapy, whereby antidepressants from the selective serotonin reuptake inhibitor group [e.g. sertraline (n = 21), escitalopram, paroxetine, fluoxetine] but also clomipramine (a tricyclic antidepressant) were predominantly used. Moreover, seven of the patients received a combination treatment (mainly a sedating antipsychotic medication, e.g. promethazine or quetiapine). At the time of inclusion in the study, 12 patients were receiving psychotherapeutic treatment (validation therapy: n = 9; deep psychology: n = 3). Only five of the patients (16.1%) with OCD had not received psychotherapy at the time of study inclusion, either currently or in the past. A detailed anamnesis was taken from all OCD patients and healthy volunteers in a semi-structured interview (duration 45–60 min). The psychometric characteristics, including shame and guilty proneness, were gathered using various questionnaires.
The study was approved by the local Ethics Committee (No. 20–6883) of the Medical Faculty of Ruhr-University Bochum.
Mavrogiorgou P., Becker S., Lee-Grimm S.I, & Juckel G. (2023). Embitterment and metacognition in obsessive–compulsive disorder. BMC Psychiatry, 23, 146.
Full text: Click here
Publication 2023
Antidepressive Agents Antipsychotic Agents Brain Diseases Clomipramine Diagnosis Diploid Cell Drug Dependence Escitalopram Faculty, Medical Fluoxetine Guilt Healthy Volunteers Immunologic Memory Males Paroxetine Patients Promethazine Psychometrics Psychotherapy Psychotic Disorders Psychotropic Drugs Quetiapine Regional Ethics Committees Schizophrenia Selective Serotonin Reuptake Inhibitors Sertraline Shame Student Therapeutics Tricyclic Antidepressive Agents Woman
2
Self-Compassion Intervention for Shame Reduction
A power analysis for a repeated-measures between-subjects analysis of variance (ANOVA) design conducted in G*Power (Faul et al., 2009 (link)) yielded a total target sample size of 62 to detect a medium effect size with 80% power. Given that there is no gold standard power analysis method for multilevel modeling, and previous studies demonstrated small to medium increases in self-compassion and medium to large reductions in shame in samples of 40–90 (e.g., Johnson & O’Brien, 2013 (link); Kelly & Waring, 2018 (link)), we aimed for a total target enrollment of 60 participants, 30 per group.
The final sample for this study comprised 68 undergraduate students recruited through the university’s online research system, flyers posted around campus, and departmental e-mail listservs. Inclusion criteria were being 18 years of age or older, self-reported English fluency in speaking, reading, and writing, and baseline scores ≥ 65 on the Experience of Shame Scale (ESS; Andrews et al., 2002 (link)). Though there is no established cut-off score on the ESS to indicate clinically meaningful shame, research in an English-speaking undergraduate sample indicated that the mean ESS score was 55.58 (SD = 13.95; Andrews et al., 2002 (link)), suggesting that the 75th percentile of ESS scores falls at approximately a score of 65, which was used as the minimal cut-off score for the current study.
Demographic characteristics of the sample are displayed in Table 1. Sixty-eight participants completed the baseline assessment (nintervention = 29; ncontrol = 39), 50 participants completed the post-intervention assessment (nintervention = 20; ncontrol = 30), and 32 participants completed the follow-up assessment (nintervention = 15; ncontrol = 17).

Demographic and baseline clinical characteristics of sample (n = 68)

Intervention Group (n = 29)Control Group (n = 39)Statistical Test
Mean or nSD or %Mean or nSD or %
Age (M, SD)20.292.2620.593.62t(65) = -0.39
Female (n, %)2586.23076.9χ2(1) = 0.93
Gender minority (n, %)13.437.7χ2(1) = 0.54
Sexual orientation minority (n, %)1344.81743.6χ2(1) = 0.004
Racial identity (n, %)χ2(3) = 1.09
  Black/African American26.9615.4–
  Asian517.2717.9–
  White1758.62359.0–
  Other (e.g., mixed race)310.337.7–
  Missing or not reported26.9–––
Ethnicity (n, %)χ2(1) = 1.81
  Hispanic517.237.7–
  Non-Hispanic2172.43589.7–
  Missing or not reported310.312.6–
Concurrent treatment (n, %)931.01846.2χ2(1) = 1.59
Change in treatment (n, %)310.337.7χ2(1) = 0.66
Average # letters written8.176.18–––
ESS79.179.5477.569.44t(66) = 0.69
OAS-218.837.1618.725.44t(66) = 0.07
FSCRS-IS23.556.1522.976.35t(66) = 0.38
SCS-SF28.667.7127.956.75t(66) = 0.40
PHQ-913.176.4713.775.17t(66) = -0.42
GAD-712.725.0412.054.49t(66) = 0.58

Gender minority = gender identity other than cisgender; sexual orientation minority = sexual orientation other than heterosexual; concurrent treatment = receiving psychotherapy or psychotropic medication at the time of beginning the study; change in treatment = change in psychotherapy or psychotropic medication over the course of the study; average # letters written = the average number of completed days of the intervention; ESS Experience of Shame Scale, OAS-2 Other As Shamer Scale-2, FSCRS-IS Forms of Self Criticizing/Attacking and Self-Reassuring Scale, Inadequate Self Subscale, SCS-SF Self-compassion Scale-Short form, PHQ-9 Patient Health Questionnaire-9, GAD-7 Generalized Anxiety Disorder 7-item Scale. None of the tests were statistically significant

Swee M.B., Klein K., Murray S, & Heimberg R.G. (2023). A Brief Self-Compassionate Letter-Writing Intervention for Individuals with High Shame. Mindfulness, 14(4), 854-867.
Publication 2023
Ethnicity Gender Identity Gold Heterosexuals Minority Groups Negroid Races Psychotherapy Psychotropic Drugs Self-Compassion Sexual and Gender Minorities Sexual Orientation Shame Student
3
Evaluating External Shame with OAS-2
The OAS-2 is an 8-item version of the original OAS (Goss et al., 1994 (link)), which measures external shame. The OAS-2 asks individuals to rate how frequently they experience external shame on a 5-point Likert-type scale, such that higher scores indicate greater external shame. The OAS-2 demonstrated strong internal consistency (α = 0.82), as well as a large correlation with the original OAS (r = 0.91) and a moderate correlation with the ESS (r = 0.54; Matos et al., 2015 (link)). The OAS-2 demonstrated strong reliability in our sample at baseline (α = 0.85, ω = 0.85), post-assessment (α = 0.90, ω = 0.90), and follow-up (α = 0.95, ω = 0.95).
Swee M.B., Klein K., Murray S, & Heimberg R.G. (2023). A Brief Self-Compassionate Letter-Writing Intervention for Individuals with High Shame. Mindfulness, 14(4), 854-867.
Publication 2023
Shame
4
Shame Assessment with the ESS
The ESS is a 25-item measure of global shame that probes characterological, behavioral, and bodily shame. Items are rated on a 4-point Likert-type scale based on the past year. Scores on the ESS range from 25–100, with higher scores indicating higher levels of shame. The ESS has shown strong internal consistency (α = 0.92), good 11-week test–retest reliability (r = 0.88), and strong convergent validity with other measures of shame (Andrews et al., 2002 (link)). The ESS demonstrated strong internal consistency and scale reliability in our sample at baseline (α = 0.83, ω = 0.79), post-assessment (α = 0.94, ω = 0.94), and follow-up (α = 0.94, ω = 0.94).
Swee M.B., Klein K., Murray S, & Heimberg R.G. (2023). A Brief Self-Compassionate Letter-Writing Intervention for Individuals with High Shame. Mindfulness, 14(4), 854-867.
Publication 2023
Shame
5
Sexual Health and Well-being Survey of Québécois Adults
A non-probabilistic adult sample of 2,154 Québécois (Canada) individuals was recruited via social media (i.e., Facebook and Instagram) from June to September 2021. Participants were invited to complete an anonymous online survey on sexual health and well-being in either French or English. Specifically, the community-based survey comprised ten sections assessing participants’ sexual difficulties (e.g., SD, problematic pornography consumption, sexualized drug use) and related issues (e.g., body shame, attachment insecurities, performance anxiety, sexual victimization), psychological and relational well-being, and barriers to treatment access. By clicking on the study link, participants were led to a consent form detailing the study’s nature and objectives, which they needed to review and sign electronically. After providing electronic consent, participants accessed the survey, hosted on Qualtrics. The survey took about 30 to 40 minutes to complete. Of the 2,154 participants who provided consent, 87.8% (n = 1,891) met the inclusion criteria, namely: (1) being at least 18 years old, (2) having sufficient knowledge of either French or English, and (3) completing at least 70% of the measures of interest. Individuals who did not meet these criteria were excluded from the present study. Participants were eligible to enter a draw to win one of 30 gift-cards with a value ranging from $25 to $200 CAD.
Lafortune D., Girard M., Dussault É., Philibert M., Hébert M., Boislard M.A., Goyette M, & Godbout N. (2023). Who seeks sex therapy? Sexual dysfunction prevalence and correlates, and help-seeking among clinical and community samples. PLOS ONE, 18(3), e0282618.
Full text: Click here
Publication 2023
Adult Anxiety, Performance Human Body Pharmaceutical Preparations Sexual Health Shame Victimization

Top products related to «Shame»

1
Spss version 26 by IBM
Sourced in United States, Japan, United Kingdom, Germany, Austria, Canada, Belgium, Spain
SPSS version 26 is a statistical software package developed by IBM. It is designed to perform advanced statistical analysis, data management, and data visualization tasks. The software provides a wide range of analytical tools and techniques to help users understand and draw insights from their data.
2
Spss version 21 by IBM
Sourced in United States, Japan, United Kingdom, Germany, Austria, Belgium, Denmark, China, Israel, Australia
SPSS version 21 is a statistical software package developed by IBM. It is designed for data analysis and statistical modeling. The software provides tools for data management, data analysis, and the generation of reports and visualizations.
3
Dnazol by Thermo Fisher Scientific
Sourced in United States, United Kingdom
DNAzol is a reagent used for the isolation and purification of genomic DNA from various biological samples. It is designed to facilitate the extraction and recovery of high-quality DNA for use in downstream molecular biology applications.
4
X gal by MP Biomedicals
Sourced in United States
X-gal is a chromogenic substrate used in molecular biology and biochemistry. It is commonly used to detect the presence of the enzyme β-galactosidase, which catalyzes the hydrolysis of lactose. When β-galactosidase is present, X-gal is cleaved, resulting in a blue colored product. This property makes X-gal a useful tool for various applications, such as blue-white screening in bacterial gene cloning and reporter gene assays.
5
Spss version 27 by IBM
Sourced in United States, United Kingdom, Germany, Japan, Austria, Canada
SPSS version 27 is a statistical software package developed by IBM. It provides tools for data management, analysis, and reporting. The core function of SPSS is to enable users to perform a wide range of statistical analyses on their data, including descriptive statistics, regression analysis, and hypothesis testing.
6
Quantitative colorimetric calcium assay kits by BioChain
Sourced in United States
The Quantitative colorimetric calcium assay kits are laboratory equipment used to measure the concentration of calcium in a sample through a colorimetric reaction. The kits provide a quantitative analysis of calcium levels.
7
Spss version by IBM
Sourced in United States, United Kingdom, Japan, Germany
SPSS is a software package used for statistical analysis. It provides a graphical user interface and a robust set of tools for data manipulation, analysis, and visualization. SPSS is designed to handle a wide range of data types and supports a variety of statistical techniques, including regression analysis, factor analysis, and time series analysis.
8
Mouse proinflammatory 7 plex ultra sensitive kit by Mesoscale
Sourced in United States
The Mouse ProInflammatory 7-Plex Ultra-Sensitive Kit is a laboratory equipment product designed for the quantitative measurement of seven mouse pro-inflammatory cytokines in a single sample. The kit utilizes a multiplexed immunoassay technology to detect and quantify the target analytes.
9
Nvivo qualitative software by Lumivero
NVivo is a qualitative data analysis software package. It is designed to assist in organizing and analyzing unstructured data, such as interviews, focus groups, and open-ended survey responses. The software provides tools for coding, categorizing, and identifying themes within the data.
10
Stata 12 by StataCorp
Sourced in United States, United Kingdom, Denmark, Belgium, Spain, Canada, Austria
Stata 12.0 is a comprehensive statistical software package designed for data analysis, management, and visualization. It provides a wide range of statistical tools and techniques to assist researchers, analysts, and professionals in various fields. Stata 12.0 offers capabilities for tasks such as data manipulation, regression analysis, time-series analysis, and more. The software is available for multiple operating systems.

More about "Shame"

Shame is a complex emotional experience characterized by intense feelings of self-consciousness, inadequacy, and a perceived negative evaluation by others.
This social emotion can have profound impacts on an individual's mental health and behavior.
Shame is often associated with experiences of social rejection, public humiliation, or the failure to meet societal expectations.
Researchers can leverage this understanding to enhance their inquiries into the psychological, physiological, and behavioral manifestations of shame, as well as its role in various mental health conditions and interpersonal dynamics.
Synonyms and related terms for shame include embarrassment, mortification, humiliation, and ignominy.
Abbreviations such as SH may be used to denote shame in research contexts.
Key subtopics include the neurological and physiological correlates of shame, the role of shame in the development and maintenance of mental health disorders like depression and social anxiety, and the interpersonal and cultural factors that influence shame experiences.
Analytic tools like SPSS (versions 21, 26, and 27), Stata 12.0, and NVivo qualitative software can be leveraged to investigate shame-related phenomena.
Biochemical assays like the DNAzol reagent, X-gal, and Quantitative colorimetric calcium assay kits may also provide insights into the biological underpinnings of shame.
Additionally, the Mouse ProInflammatory 7-Plex Ultra-Sensitive Kit could be used to examine the cytokine profiles associated with shame-inducing experiences.
By integrating these multidisciplinary approaches, researchers can deepen our understanding of shame and its implications for individual well-being and interpersonal dynamics.
This knowledge can ultimately inform more effective interventions and strategies for addressing the challenges posed by this complex emotional experience.